Released: 02/28/2020 Expires: 11/30/2021 (subject to change)
CE for this activity will not be available after this date.
Overview Tobacco use is the leading cause of preventable illness and death in the United States and worldwide. Each year, 480,000 deaths in the United States and 7 million deaths around the world are attributable to tobacco use. Dr. Joelle Fathi, DNP, RN, ARNP, CTTS guides the learner through smoking cessation counseling and pharmacotherapy in this activity. Role playing vignette videos allow the learner to see counseling techniques applied to a case scenario. CE Credit Instructions
Read this activity description, including objectives and disclosures.
Complete the educational content completely:
Video Presentations: Watch all video presentations completely.
Review all additional materials provided (handouts, posttest reviews, any other downloadable resources).
After completing all content, go to Steps to Receive Credit:
Complete the posttest
Submit the evaluation to receive full AANP CE/Rx credit.
Explain the importance of asking every patient about smoking at every visit.
Discuss the relevance of treating tobacco use as a chronic disease.
Identify guideline-recommended and evidence-based methods for improving the rates of successful smoking cessation.
Discuss the role of the nurse practitioner in addressing barriers and preventing relapse.
Describe the results of randomized controlled trials and real-world studies of smoking cessation pharmacotherapy alone and in combination with other methods.
Describe barriers to successful smoking cessation attempts.
Identify the ways in which counseling, pharmacotherapy, and nicotine replacement therapy can overcome these barriers.
Discuss mechanisms of action of smoking cessation pharmacotherapies, including nicotine replacement therapy.
Speakers Joelle Fathi, DNP, RN, ARNP, CTTS Disclosure This program was planned in accordance with AANP CE Standards and Policies.
Dr. Joelle Fathi has no disclosures.
AANP planners have no relevant financial relationships to disclose.
This educational activity may contain opinions of the authors from their personal experience. The activity may contain discussion of published and/ or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Further, attendees/ participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program. Disclaimer Individuals who have contributed to the CE Center were carefully selected for their knowledge and experience in the subject area under review. This presentation is informational only and may contain opinions of the authors from their personal experience that do not necessarily express the opinions of the American Association of Nurse Practitioners (AANP). The activity may contain discussion of published and/or investigational uses of agents that are not indicated by the FDA. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications, and warnings. Clinical practice is a constantly changing process and new information becomes available every day. Neither AANP nor the contributing individuals can warrant that the material will continue to be accurate, nor do they warrant that the material is completely free of errors upon publication. Attendees and participants should appraise the information presented critically and are encouraged to consult appropriate resources for any product or device mentioned in this program. Additional Information For questions or more information concerning this online CE opportunity contact the AANP CE Center Manager at CECenter@aanp.org.
1.25 Contact Hour(s) of CE, 0.75 of which may be applied towards Pharmacology